Consensus statement on the use of rituximab in patients with rheumatoid arthritis

被引:168
作者
Smolen, J. S.
Keystone, E. C.
Emery, P.
Breedveld, F. C.
Betteridge, N.
Burmester, G. R.
Dougados, M.
Ferraccioli, G.
Jaeger, U.
Klareskog, L.
Kvien, T. K.
Martin-Mola, E.
Pavelka, K.
机构
[1] Med Univ Vienna, Dept Internal Med 3, Dept Rheumatol, Div Rheumatol, A-1090 Vienna, Austria
[2] Hietzing Hosp Vienna, Dept Med 2, Vienna, Austria
[3] Univ Toronto, Mt Sinai Hosp, Rebecca MacDonald Ctr Arthrit & Autoimmun, Toronto, ON M5G 1X5, Canada
[4] Chapel Allerton Hosp, Leeds Teaching Hosp Trust, Leeds, W Yorkshire, England
[5] Arthrit Care, London, England
[6] Leiden Univ, Sch Med, NL-2300 RA Leiden, Netherlands
[7] Humboldt Univ, Charite Hosp, Dept Rheumatol, D-1086 Berlin, Germany
[8] Univ Paris 05, Hop Cochin, Dept Rheumatol, F-75270 Paris 06, France
[9] Univ Cattolica Sacro Cuore, Inst Internal Med & Geriatr, Div Rheumatol, I-00168 Rome, Italy
[10] Med Univ Vienna, Dept Internal Med 1, Div Haematol, A-1090 Vienna, Austria
[11] Karolinska Hosp, Dept Rheumatol, S-10401 Stockholm, Sweden
[12] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway
[13] Univ Autonoma Madrid, Hosp La Paz, Dept Rheumatol, E-28049 Madrid, Spain
[14] Charles Univ Prague, Inst Rheumatol, CR-11636 Prague 1, Czech Republic
[15] Charles Univ Prague, Clin Rheumatol, CR-11636 Prague 1, Czech Republic
关键词
D O I
10.1136/ard.2006.061002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A large number of experts experienced in the treatment of rheumatoid arthritis were involved in formulating a consensus statement on the use of B cell-targeted treatment with rituximab in patients with rheumatoid arthritis. The statement was supported by data from randomised controlled clinical trials and the substantial literature on oncology. The statement underwent three rounds of discussions until its ultimate formulation. It should guide clinicians in the use of this newly approved biological agent in treating patients with rheumatoid arthritis.
引用
收藏
页码:143 / 150
页数:8
相关论文
共 42 条
[1]   The definition and measurement of disease modification in inflammatory rheumatic diseases [J].
Aletaha, D ;
Smolen, JS .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2006, 32 (01) :9-+
[2]   Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states [J].
Aletaha, D ;
Ward, MM ;
Machold, KP ;
Nell, VPK ;
Stamm, T ;
Smolen, JS .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2625-2636
[3]  
Bermúdez A, 2000, HAEMATOLOGICA, V85, P894
[4]   Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma [J].
Boue, Francois ;
Gabarre, Jean ;
Gisselbrecht, Christian ;
Reynes, Jacques ;
Cheret, Antoine ;
Bonnet, Fabrice ;
Billaud, Eric ;
Raphael, Martine ;
Lancar, Remi ;
Costagliola, Dominique .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) :4123-4128
[5]  
BREEDVELD FC, 2006, ANN RHEUM DIS S1, V65
[6]  
Carr A, 2003, J RHEUMATOL, V30, P880
[7]  
Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18
[8]   Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks [J].
Cohen, Stanley B. ;
Emery, Paul ;
Greenwald, Maria W. ;
Dougados, Maxime ;
Furie, Richard A. ;
Genovese, Mark C. ;
Keystone, Edward C. ;
Loveless, James E. ;
Burmester, Gerd-Ruediger ;
Cravets, Matthew W. ;
Hessey, Eva W. ;
Shaw, Timothy ;
Totoritis, Mark C. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2793-2806
[9]   EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) [J].
Combe, B. ;
Landewe, R. ;
Lukas, C. ;
Bolosiu, H. D. ;
Breedveld, F. ;
Dougados, M. ;
Emery, P. ;
Ferraccioli, G. ;
Hazes, J. M. W. ;
Klareskog, L. ;
Machold, K. ;
Martin-Mola, E. ;
Nielsen, H. ;
Silman, A. ;
Smolen, J. ;
Yazici, H. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (01) :34-45
[10]  
Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO